| (Aug. 13, 2021, 4:40 a.m.) -- In a late night Aug. 12 announcement, the U.S. Food and Drug administration (FDA) says it has approved an emergency use authorization for a third shot of the Pfizer and Moderna vaccines for certain Immunocompromised individuals who previously received two shots of the same vaccines.
The action doesn't apply to persons who are not immunocompromised. The FDA now allows an additional dose of the Pfizer and Moderna vaccines for immunocompromised individuals who are solid organ transplant recipients or to those diagnosed with conditions considered to have an equivalent level of immunocompromise. . "The authorizations for these vaccines have been amended to allow for an additional, or third, dose to be administered at least 28 days following the two-dose regimen of the same vaccine to individuals 18 years of age or older (ages 12 or older for Pfizer-BioNTech) who have undergone solid organ transplantation, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise, the FDA release said.. The FDA release indicates that later today (Aug 13) the CDC's "Advisory Committee on Immunization Practices" is scheduled to meet to discuss "further clinical recommendations regarding immunocompromised individuals." Today’s action The FDA's full release is at this link. + |      |
